A clinical trial to evaluate the safety and efficacy of multiple doses of ABT-719 to prevent acute kidney injury in patients undergoing high risk heart surgery

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003942-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The study objective is to compare the safety and efficacy of doses of 800 mcg/kg, 1600 mcg/kg and 2100 mcg/kg intravenous (IV) infusions of ABT-719 to placebo in subjects who are at risk of AKI and undergoing pre-defined on-pump cardiac surgery.


Critère d'inclusion

  • acute kidney injury

Liens